Read as much as you want on BostonGlobe.com, anywhere and anytime, for just 99¢.

Mass. Movers

Danvers’ Abiomed falls on downgrade

Abiomed’s AbioCor Total Replacement Heart.

ABIOMED INC.

Abiomed’s AbioCor Total Replacement Heart.

Continue reading below

Shares of Danvers-based Abiomed Inc. fell following a downgrade from overweight to neutral by analysts at Piper Jaffray. They are concerned over balancing risks related to Food and Drug Administration premarket approval, and benefits from opportunities including a growing product pipeline, new markets like Japan, and favorable reimbursements. Abiomed develops, manufactures, and markets technologies designed to help or replace the pumping function of the heart.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week